DEFEROXAMINE MESYLATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for deferoxamine mesylate and what is the scope of patent protection?

Deferoxamine mesylate is the generic ingredient in two branded drugs marketed by Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, West-ward Pharms Int, and Novartis, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for deferoxamine mesylate. Six suppliers are listed for this compound.

Sponsor	Phase
Aditya S. Pandey, MD	Phase 2
Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research	Phase 2
Beijing Pinggu District Hospital	Phase 1/Phase 2

Sponsor

Phase

Aditya S. Pandey, MD

Phase 2

Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research

Phase 2

Beijing Pinggu District Hospital

Phase 1/Phase 2

US Patents and Regulatory Information for DEFEROXAMINE MESYLATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	DESFERAL	deferoxamine mesylate	INJECTABLE;INJECTION	016267-002	May 25, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	DEFEROXAMINE MESYLATE	deferoxamine mesylate	INJECTABLE;INJECTION	078718-001	Sep 15, 2009	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
West-ward Pharms Int	DEFEROXAMINE MESYLATE	deferoxamine mesylate	INJECTABLE;INJECTION	078086-002	May 30, 2007	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Gland Pharma Ltd	DEFEROXAMINE MESYLATE	deferoxamine mesylate	INJECTABLE;INJECTION	207384-001	Sep 29, 2017	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	DESFERAL	deferoxamine mesylate	INJECTABLE;INJECTION	016267-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

Novartis

DESFERAL

deferoxamine mesylate

INJECTABLE;INJECTION

016267-001

Approved Prior to Jan 1, 1982

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	6
NDAs:	6
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	6
Patent Applications:	2,280
Drug Prices:	Drug price trends for DEFEROXAMINE MESYLATE
What excipients (inactive ingredients) are in DEFEROXAMINE MESYLATE?	DEFEROXAMINE MESYLATE excipients list
DailyMed Link:	DEFEROXAMINE MESYLATE at DailyMed

Drug Class	Iron Chelator
Mechanism of Action	Iron Chelating Activity

DEFEROXAMINE MESYLATE - Generic Drug Details

What are the generic drug sources for deferoxamine mesylate and what is the scope of patent protection?

Summary for DEFEROXAMINE MESYLATE

Recent Clinical Trials for DEFEROXAMINE MESYLATE

Pharmacology for DEFEROXAMINE MESYLATE

Medical Subject Heading (MeSH) Categories for DEFEROXAMINE MESYLATE

Anatomical Therapeutic Chemical (ATC) Classes for DEFEROXAMINE MESYLATE

US Patents and Regulatory Information for DEFEROXAMINE MESYLATE

Expired US Patents for DEFEROXAMINE MESYLATE

Make Better Decisions: Try a trial or see plans & pricing